The financials were a sideshow as investors focused on the company's potential vaccines for the COVID-19 coronavirus and congenital cytomegalovirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,